Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibrin self-assembly interfaces are the specific molecular contact points responsible for the polymerization of fibrin monomers into a stable, three-dimensional blood clot. This process is initiated when thrombin cleaves fibrinopeptides A and B from fibrinogen, exposing N-terminal "knobs" (A and B) that bind to complementary "holes" (a and b) located in the C-terminal domains of neighboring fibrin molecules (MedlinePlus, 2023; PubMed: 15153610). The A-a interaction is essential for the longitudinal growth of protofibrils, while the B-b interaction facilitates lateral aggregation and branching of the fibrin network (UniProt: P02671). Because these interfaces are the final structural step in clot formation, they represent a unique therapeutic target for anticoagulants designed to prevent thrombosis without broadly inhibiting the enzymatic cascade of coagulation (PubMed: 21844475). Experimental drugs, such as GPRP-based peptides, work by mimicking the knobs and occupying the holes, thereby blocking the assembly of the fibrin matrix (PubMed: 11586356). These interfaces are also critical in the context of wound healing and tissue engineering, where the mechanical properties of the fibrin scaffold are determined by the strength and density of these interactions.
Competitive inhibition of knob-hole interactions to prevent fibrin polymerization.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibrin self-assembly interfaces.